Telefon:: +49 (0)241 95 163 153
Fax:: +49 (0)241 95 163 155
E-Mail:: orders@antikoerper-online.de

Aktivieren Sie Javascript in Ihrem Browser, um unsere Webseite optimal zu nutzen.

Spastic Paraplegia 20 (Troyer Syndrome) (SPG20) Peptid

SPG20 Reaktivität: Säugetier Wirt: Synthetic BP, WB, IHC

Produktnummer ABIN936930

382,12 €

Zzgl. Versandkosten 20,00 € und MwSt

100 μg

Lieferung nach: Deutschland

Lieferung in 20 bis 27 Werktagen

Kurzübersicht für Spastic Paraplegia 20 (Troyer Syndrome) (SPG20) Peptid (ABIN936930)

Target

SPG20 (Spastic Paraplegia 20 (Troyer Syndrome) (SPG20))

Spezies

Säugetier

Quelle

Synthetic

Applikation

Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)

Protein-Typ

Synthetic

Sequenz

ASWVSWGLVK GAEITGKAIQ KGASKLRERI QPEEKPVEVS PAVTKGLYIA

Produktmerkmale

A synthetic peptide for use as a blocking control in assays to test for specificity of SPG20 antibody,
Alternative Names: SPG20 control peptide, SPG20 antibody Blocking Peptide, Anti-SPG20 Blocking Peptide, Spastic Paraplegia 20 Blocking Peptide, Troyer Syndrome Blocking Peptide, KIAA0610 Blocking Peptide, SPARTIN Blocking Peptide, TAHCCP1 Blocking Peptide, SPG20, SPG-20, SPG 20, SPG-20 Blocking Peptide, SPG 20 Blocking Peptide
Spastic Paraplegia 20 (Troyer Syndrome) (SPG20) peptide
SPG20 Wirt: Synthetic BP, Imm

Spastic Paraplegia 20 (Troyer Syndrome) (SPG20) (N-Term) peptide
SPG20 Reaktivität: Human Wirt: Synthetic BP, WB

Spastic Paraplegia 20 (Troyer Syndrome) (SPG20) (Middle Region) peptide
SPG20 Reaktivität: Human Wirt: Synthetic BP, WB

Spastic Paraplegia 20 (Troyer Syndrome) (SPG20) (Internal Region) peptide
SPG20 Reaktivität: Human Wirt: Synthetic BP, BI

Applikationshinweise

Optimal conditions should be determined by the investigator

Beschränkungen

Nur für Forschungszwecke einsetzbar
Format

Lyophilized

Rekonstitution

Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.

Buffer

PBS

Handhabung

Avoid repeated freeze/thaw cycles.

Lagerung

-20 °C

Informationen zur Lagerung

Store at -20 °C long term.
Target

SPG20 (Spastic Paraplegia 20 (Troyer Syndrome) (SPG20))

Hintergrund

This gene encodes a protein containing a MIT (Microtubule Interacting and Trafficking molecule) domain, and is implicated in regulating endosomal trafficking and mitochondria function. The protein localizes to mitochondria and partially co-localizes with microtubules. Stimulation with epidermal growth factor (EGF) results in protein translocation to the plasma membrane, and the protein functions in the degradation and intracellular trafficking of EGF receptor. Multiple alternatively spliced variants, encoding the same protein, have been identified.

Molekulargewicht

73 kDa

Sie sind hier: